Point-of-Care Platelet Reactivity Determination with VerifyNow-P2Y12 following Administration of Clopidogrel or Prasugrel: Data from a Real-World, Clinical Care Inpatient Setting
Jay Bae(Eli Lilly (United States)), David Drenning(Huntsville Hospital), Jamie Fortenberry(Huntsville Hospital), Juliana Meyers(RTI Health Solutions), Sean D. Candrilli(RTI Health Solutions), Joseph A. Jakubowski(Indiana Biosciences Research Institute)
Cited by 4
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617